Xiu Gong

12 Wulumuqi Road
Shanghai, 200040, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Geometric and dosimetric evaluation of auto-segmentation of brain arteriovenous malformations using multimodal imaging in stereotactic radiosurgery.

Geometric and dosimetric evaluation of auto-segmentation of brain arteriovenous malformations using multimodal imaging in stereotactic radiosurgery.

Journal: Frontiers in neuroscience

Published: June 12, 2025

Multi-reader evaluation of deep learning-based auto-segmentation of eloquent brain arteriovenous malformation on MRA and white matter tractography in stereotactic radiosurgery.

Multi-reader evaluation of deep learning-based auto-segmentation of eloquent brain arteriovenous malformation on MRA and white matter tractography in stereotactic radiosurgery.

Journal: Radiation oncology (London, England)

Published: May 10, 2025

Effect of high-field iMRI guided resection in cerebral glioma surgery: A randomized clinical trial.

Effect of high-field iMRI guided resection in cerebral glioma surgery: A randomized clinical trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 11, 2023

Long-term clinical outcomes of hypofractionated stereotactic radiotherapy using the CyberKnife robotic radiosurgery system for jugular foramen schwannomas.

Long-term clinical outcomes of hypofractionated stereotactic radiotherapy using the CyberKnife robotic radiosurgery system for jugular foramen schwannomas.

Journal: Journal of neurosurgery

Published: May 07, 2023

Dose-staged Gamma Knife radiosurgery for meningiomas: A retrospective study in a single center.

Dose-staged Gamma Knife radiosurgery for meningiomas: A retrospective study in a single center.

Journal: Frontiers in neurology

Published: March 10, 2022

Safety and Efficacy of Hypofractionated Stereotactic Radiotherapy with Anlotinib Targeted Therapy for Glioblastoma at the First Recurrence: A Preliminary Report.

Safety and Efficacy of Hypofractionated Stereotactic Radiotherapy with Anlotinib Targeted Therapy for Glioblastoma at the First Recurrence: A Preliminary Report.

Journal: Brain sciences

Published: January 12, 2022

Activation of AdipoR1 with rCTRP9 Preserves BBB Integrity through the APPL1/AMPK/Nrf2 Signaling Pathway in ICH Mice.

Activation of AdipoR1 with rCTRP9 Preserves BBB Integrity through the APPL1/AMPK/Nrf2 Signaling Pathway in ICH Mice.

Journal: Oxidative medicine and cellular longevity

Published: August 28, 2021

A phase II open label, single arm study of hypofractionated stereotactic radiotherapy with chemoradiotherapy using intensity-modulated radiotherapy for newly diagnosed glioblastoma after surgery: the HSCK-010 trial protocol.

A phase II open label, single arm study of hypofractionated stereotactic radiotherapy with chemoradiotherapy using intensity-modulated radiotherapy for newly diagnosed glioblastoma after surgery: the HSCK-010 trial protocol.

Journal: BMC cancer

Published: August 16, 2021

Hypoxia-induced RNASEH2A limits activation of cGAS-STING signaling in HCC and predicts poor prognosis.

Hypoxia-induced RNASEH2A limits activation of cGAS-STING signaling in HCC and predicts poor prognosis.

Journal: Tumori

Published: June 24, 2021

Safety and efficacy of Hypofractionated stereotactic radiosurgery for high-grade Gliomas at first recurrence: a single-center experience.

Safety and efficacy of Hypofractionated stereotactic radiosurgery for high-grade Gliomas at first recurrence: a single-center experience.

Journal: BMC cancer

Published: November 22, 2020

Downregulation of Nedd4L predicts poor prognosis, promotes tumor growth and inhibits MAPK/ERK signal pathway in hepatocellular carcinoma.

Downregulation of Nedd4L predicts poor prognosis, promotes tumor growth and inhibits MAPK/ERK signal pathway in hepatocellular carcinoma.

Journal: Biochemical and biophysical research communications

Published: November 14, 2017

Neuropeptide Y1 receptor inhibits cell growth through inactivating mitogen-activated protein kinase signal pathway in human hepatocellular carcinoma.

Neuropeptide Y1 receptor inhibits cell growth through inactivating mitogen-activated protein kinase signal pathway in human hepatocellular carcinoma.

Journal: Medical oncology (Northwood, London, England)

Published: December 07, 2015

Showing 1-12 of 18

Last Updated: 09/26/2026